The California Institute of Regenerative Medicine (CIRM) has bestowed $2 million upon the Keck School of Medicine of USC to support advanced operational and technological capabilities at the new USC/CHLA cGMP Laboratory.

The cGMP Lab is a state-of-the-art facility designed to advance early-stage research on cell and gene therapies and to expedite the translation of these therapies from the lab to the clinic. In order to do this, the facility needs advanced technological know-how, streamlined operations and strict protocols for developing and testing these products, all of which the CIRM grant will help fund.

To read the full story, click here.